Search - tctmd.com

Displaying 81 - 100 of 430

Sort: Relevancy | Date

Presentation TCT 2018

Essential Elements for a Contemporary Shock Trial

Presenter: Vladimir Dzavik, Richard Smalling, James E. Udelson

September 24, 2018

Presentation TCT 2018

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Presenter: Vladimir Dzavik, Richard Smalling, Ramesh K. Adiraju, Nicola Corvaja, Vasim Farooq, Sanjog Kalra, Barry D. Rutherford, Marco V. Wainstein

September 24, 2018

Presentation TCT 2018

Case Introduction: STEMI Patient With LM Occlusion and Subtotal Aorto-ostial Stenosis of the LAD Graft

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev, Stefan Mot, Zsolt Piroth, Lucian Marius Predescu, Li-Wah Tam

September 24, 2018

Presentation TCT 2018

Left Main PCI in Patients With STEMI

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev

September 24, 2018

Presentation TCT 2018

Post-Cath Lab Management of Shock: What's the Role of the Interventionalist?

Presenter: Vladimir Dzavik, Richard Smalling, Michael J. Lim

September 24, 2018

Presentation TCT 2018

Flash Debate #2: Impella Is the Optimal Support Platform for Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Perwaiz M. Meraj

September 24, 2018

News Conference News TCT 2018

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Michael O'Riordan

September 24, 2018

Presentation TCT 2018

Flash Debate #2: VA-ECMO Is the Optimal Support Platform for Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Michael Mooney

September 24, 2018

Presentation TCT 2018

Acute MI and ACS Cases: Mortality and Fortunate Saves

Presenter: Sreenivas Kumar Arramraju, Sreenivas Arramraju Kumar, Sahil A. Parikh, Subhash Banerjee, Raghu Cherukupalli, Manotosh Panja, Gokul M. Reddy

September 24, 2018

Presentation TCT 2018

Hub and Spoke Strategies for Cardiogenic Shock: What are the Essential Elements?

Presenter: Vladimir Dzavik, Richard Smalling, Holger Thiele

September 24, 2018

Presentation TCT 2018

Using Hemodynamics to Guide Decision-Making in Cardiogenic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Salvatore F Mannino

September 24, 2018

Presentation TCT 2018

Hemodynamic Support: Which Device for Which Patient and Why?

Presenter: Vladimir Dzavik, Richard Smalling, Daniel Burkhoff

September 24, 2018

Presentation TCT 2018

Case Introduction: My Most Complex STEMI PCI

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev, Stefan Mot, Zsolt Piroth, Lucian Marius Predescu, Li-Wah Tam

September 24, 2018

Presentation TCT 2018

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Presenter: Vladimir Dzavik, Richard Smalling, Navin K. Kapur

September 24, 2018

Presentation TCT 2018

Case Introduction: My Most Complex STEMI PCI

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Valeri Ljubenov Gelev, Stefan Mot, Zsolt Piroth, Lucian Marius Predescu, Li-Wah Tam

September 24, 2018

Presentation TCT 2018

Is Multivessel Revascularization During Primary PCI in STEMI Necessary, Desirable, or Contraindicated?

Presenter: Michael Kang-Yin Lee, Ivo Petrov, Marin Postu, Zoltan Ruzsa, Stefan Mot

September 24, 2018

Presentation TCT 2018

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Presenter: Anthony H. Gershlick, Pieter C. Smits, Marwan F. Jumean

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Deepak L. Bhatt

September 24, 2018

Presentation TCT 2018

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

Presenter: Anthony H. Gershlick, Pieter C. Smits, Thomas Engstrøm

September 24, 2018

Presentation TCT 2018

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Presenter: Anthony H. Gershlick, Pieter C. Smits, Joo Myung Lee

September 24, 2018

Advertisement

Essential Elements for a Contemporary Shock Trial

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Case Introduction: STEMI Patient With LM Occlusion and Subtotal Aorto-ostial Stenosis of the LAD Graft

Left Main PCI in Patients With STEMI

Post-Cath Lab Management of Shock: What's the Role of the Interventionalist?

Flash Debate #2: Impella Is the Optimal Support Platform for Cardiogenic Shock

More GLOBAL LEADERS: No Benefit of Ticagrelor Monotherapy in New Analyses

Flash Debate #2: VA-ECMO Is the Optimal Support Platform for Cardiogenic Shock

Acute MI and ACS Cases: Mortality and Fortunate Saves

Hub and Spoke Strategies for Cardiogenic Shock: What are the Essential Elements?

Using Hemodynamics to Guide Decision-Making in Cardiogenic Shock

Hemodynamic Support: Which Device for Which Patient and Why?

Case Introduction: My Most Complex STEMI PCI

Defining Cardiogenic Shock for 2018 and the Future: Hemodynamic vs Hemometabolic Shock

Case Introduction: My Most Complex STEMI PCI

Is Multivessel Revascularization During Primary PCI in STEMI Necessary, Desirable, or Contraindicated?

Case Presentation #2: A High-Risk, Complex Patient With STEMI and Multivessel Disease

Flash Debate #1: Based on What We Dont Know - Culprit Lesion Only PCI With a Conservative Approach Is the Preferred Strategy!

Flash Debate #1: Based on What We Know - Routine Multivessel Revascularization (Acute or Delayed) Is the Preferred Strategy!

The Role of FFR, iFR, and iMR in Assessing Non-Culprit Lesions and Vessels in STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content